TekCyte Limited logo — A new global standard in biomedical coatings.

TekCyte Limited

A new global standard in biomedical coatings.

Founded 2018 Australia Australia 9 employees

General Information

Company Name TekCyte Limited
Founded Year 2018
Location Australia Australia +1
Employees 9
Social

Get notified when TekCyte Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TekCyte Limited

TekCyte Limited is a promising startup that aims to revolutionize the biomedical industry with its cutting-edge coatings. Established in 2018 and headquartered in Adelaide, Australia, TekCyte has emerged from the Cooperative Research Centre (CRC) for Cell Therapy Manufacturing. The company's flagship product, BIOINVISIBLE™, is a game-changing biocompatible coating designed for medical devices to enhance their performance by making them 'invisible' to the body’s immune system. With a team of world-leading experts, TekCyte is dedicated to the development and manufacturing of advanced coatings for medical and biomedical applications. As a potential investment opportunity, TekCyte's innovative approach in a niche market presents an intriguing potential for market disruption and future growth. The company's commitment to solving critical challenges in the medical field could attract interest from venture capital firms looking to support groundbreaking technologies with significant societal impact. Furthermore, TekCyte's strong foundation in research and development, coupled with its commercial scalability, positions the company as an attractive prospect for investors seeking opportunities in the healthcare and biotechnology sectors. For venture capital firms seeking to diversify their portfolio with unique and impactful ventures, exploring a partnership with TekCyte could offer a promising avenue for growth and innovation in the biomedical coatings industry. Overall, TekCyte's potential to redefine medical device coatings on a global scale makes it a compelling consideration for venture capital investment.

Taxonomy: Biomedical coatings, Medical devices, BIOINVISIBLE™, Biocompatible coating, Cell therapy manufacturing, Adelaide, Australia, Commercial partners, Biomedical applications, Immune system, Cooperative Research Centre, Specialized team, Advanced coatings, Commercial scalability, Global standard, Expertise

No funding data available for TekCyte Limited yet.

Get notified when TekCyte Limited raises funding

TekCyte Limited Alternatives & Competitors

TekCyte Limited vs
Biocoat
Biocoat United States

Specialists in supplying hydrophilic coatings and dip coating equipment for medical devices.

71 employees
Medical Devices
TekCyte Limited vs
Minamo
Minamo Iceland

Innovating surfaces. Transforming lives.

2 employees
TekCyte Limited vs
TEX-COTE®
TEX-COTE® United States

**Under New Ownership** Tex-Cote LLC, is a newly acquired, wholly owned subsidiary of Tnemec Company...

31 employees
Manufacturing

FAQ About TekCyte Limited

A new global standard in biomedical coatings.
TekCyte Limited was founded in 2018.
TekCyte Limited is headquartered in Australia.
TekCyte Limited has approximately 9 employees.
Top alternatives and competitors to TekCyte Limited include Biocoat, Minamo, TEX-COTE®, Caprock Manufacturing, SDC Technologies, Inc. (A division of Mitsui Chemicals). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TekCyte Limited and Biocoat are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TekCyte Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy